Golden State Wealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6K Buy
49
+13
+36% +$2.7K ﹤0.01% 1085
2026
Q1
$7.61K Hold
36
﹤0.01% 1138
2025
Q4
$7.4K Hold
36
﹤0.01% 1170
2025
Q3
$5.65K Buy
36
+2
+6% +$309 ﹤0.01% 1235
2025
Q2
$5.71K Sell
34
-25
-42% -$3.71K ﹤0.01% 1203
2025
Q1
$8.13K Hold
59
﹤0.01% 1058
2024
Q4
$6.98K Buy
+59
New +$6.89K ﹤0.01% 1042
2020
Q2
Sell
-10
Closed 290
2020
Q1
$0 Buy
+10
New +$519 ﹤0.01% 971
2019
Q4
Sell
-10
Closed 173
2019
Q3
$0 Hold
10
﹤0.01% 1073
2019
Q2
$0 Buy
+10
New +$461 ﹤0.01% 1072

Other funds holding CAH

Golden State Wealth Management's CAH Position: Q2 2026 in Review

Golden State Wealth Management increased its Cardinal Health (CAH) stake by 36% in Q2 2026, buying an estimated $2.7K and bringing the position to 49 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Golden State Wealth Management first reported a position in CAH in Q2 2019 and has held it in 10 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Golden State Wealth Management held 49 shares of Cardinal Health worth $11.6K as of Q2 2026.
  • Golden State Wealth Management bought 13 Cardinal Health shares in Q2 2026, an estimated $2.7K.
  • Cardinal Health made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1085 holding.
  • Golden State Wealth Management first reported a position in Cardinal Health in Q2 2019 and has held it in 10 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.